Metric properties of clinimetric indexes for non-motor dysfunction of Parkinson's disease in Mexican population;Propiedades métricas de instrumentos de disfunción no motora en enfermedad de Parkinson en población mexicana

Revista de Investigacion Clinica

Volumn 62, Issue 1, 2010, Pages 8-14

  Cervantes Arriàga, Amin ^a   Rodríguez Violante, Mayela ^a   Villar Velarde, Alejandra ^a   López Gómez, Mario ^a   Teresa Corona, ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Clinimetric; Non motor dysfunction; Non motor symptoms; Parkinson's disease; Scales

Indexed keywords

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; NON MOTOR SYMPTOM QUESTIONNAIRE; NON MOTOR SYMPTOM SCALE; PARKINSON DISEASE; QUESTIONNAIRE; SCALES FOR OUTCOMES IN PARKINSON DISEASE AUTONOMIC FUNCTION QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM;

AGED; FEMALE; HUMANS; LANGUAGE; MALE; MEXICO; MIDDLE AGED; OUTPATIENTS; PARKINSON DISEASE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 77952126341     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245 (Pubitemid 43238347)
2. Gulati A, Forbes A, Stegie F, Kelly L, Clough C, Chaudhauri KR. A clinical observational study of the pattern and ocurrence of non-motor symproms in Parkinson's disease ranging from early to advanced disease. Mov Disord 2004; 19(Suppl. 9): S406.
3. O'Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov Disord 2007; 23: 101-106
4. Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkisnon's disease: frequent and disabling. Neurology 2002; 59: 408-413 (Pubitemid 34857934)
5. Forsaa EB, Larsen JP, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008; 23: 1420-1507
6. Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol 2008; 255(Suppl. 5): 33-38
7. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-210. (Pubitemid 36007810)
8. Chaudhuri KR, Yates L, Martínez-Martín P. The non-motor symptom complex of Parkinson's disease. A comprenhensive assesement is essential. Curr Neurol Neurosci Rep 2005; 5: 275-283
9. Chaudhuri KR, Marínez-Martin P. Quantification of non-motor symptoms in Parkinson's disease. Eur J Neurol 2008; 15(Suppl. 2): 2-7.
10. Chaudhuri KR, Martínez-Martin P, Schapira AHV, Stocchi F, Sethi K, et al. International multicenter pilot study of the first comprehensive slef-completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest Study. Mov Disord 2006; 7: 916-923 (Pubitemid 44184590)
11. Chaudhuri KR, Martínez-Martin P, Brown RG, Sethi K, Stocchi F, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Result from an international pilot study. Mov Disord 2007; 13: 1901-1911 (Pubitemid 350134203)
12. Visser M, Marinus J, Stiggelbout AM, van Hilten JJ. Assesment of autonomic dysfunction in Parkinson's disease: The SCOPAAUT. Mov Disord 2004; 11: 1306-1312 (Pubitemid 39534547)
13. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translating adaptation. Value Health 2005; 2: 94-104. (Pubitemid 40525371)
14. Gibb WRG, Lees AJ. The relevance of Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752
15. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
16. Kulisevsky J, Pagonbarraga J. Cognitive impairment in Parkinson's diseas: tools for diagnosis and assessment. Mov Disord 2009; 24: 1103-1110
17. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442
18. McHorney TA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.
19. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993; 2: 441-449 (Pubitemid 24035216)
20. Guyatt GH, Berman LB, Townsend M, Pugsley SO, CHambers LW. A measure of quality of life in clinical trials in chronic lung disease. Thorax 1987; 42: 773-778 (Pubitemid 17142007)
21. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-592
22. Jamnadas-Khoda J, Koshy S, Mathias CJ, Muthan UB, Ragothaman M, Dodaballapur SK. Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory? Mov Disord 2009; Early View. DOI. 10.1002/mds.22537.
23. Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009; 16: 174-182
24. Silveira-Moriyama L, Carvalho MD, Katzenschlager R, et al. The use of smell identification tests in the diagnosis of Parkinson's disease in Brazil. Mov Disord 2008; 23: 2328-2334
25. Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007; 22: 1077-1092 (Pubitemid 47067217)
26. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2015-2025
27. Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2004-2014
28. Fernandez HH, Aarsland D, Fénelon G, Friedman JH, Marsh L, Tröster AI, et al. Scales to assess psychosis in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 484-500.